Maternal L-Carnitine had no significant impact on MnSOD, TOM20 and OXPHOS complexes
Yes, you can, but this introduces its own set of complexities
Youre tracking protein, drinking water, managing injections, and dealing with side effects like nausea and fatigue
Figure 2B shows that 10 6 M (1 M) Dihexa significantly protects hair cells from a range of neomycin concentrations
A pre-activated dialysis membrane (MWCO 1214 kDa, Himedia, India) was mounted between the donor and receptor compartments
Over time, pharmacological engineering enabled: Short-acting injectables (e.g., exenatide) Long-acting once-weekly injectables (liraglutide, semaglutide) Multi-target incretin therapies (tirzepatide) Oral peptide formulations and now oral small molecules The most recent breakthrough is the development of orally available GLP-1 receptor agonists, including: Orforglipron (Lilly) Elecoglipron (AstraZeneca) These compounds eliminate the need for injection and could dramatically expand accessibility and adherence in obesity and diabetes populations
